Charles River Laboratories | CRL - Eigenkapital Und Reserven

Aktienkurs
153.57
Täglich Wechseln
0.52 0.34%
Monatlich
-6.08%
Jährlich
-8.20%
Q1 Prognose
150.77




Eigenkapital Und Reserven Veränderung Datum
Agilent USD 6.91B 167M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cigna USD 41.71B 92M 2025-12
Concord Medical Services Hldg CNY -1.88B 12.91M 2023-06
CVS Health USD 75.21B 2.29B 2025-12
Danaher USD 52.53B 1.46B 2025-12
Dentsply International USD 1.34B 139M 2025-12
Elevance Health USD 44.03B 73M 2025-12
Galapagos EUR 3.24B 788.91M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Humana USD 17.66B 865M 2025-12
Illumina USD 2.72B 342M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
IQVIA Holdings USD 6.5B 343M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Lonza CHF 9.13B 513M 2025-12
McKesson USD -1.3B 441M 2025-12
Merck EUR 28.59B 344M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Quest Diagnostics USD 7.17B 88M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
United Therapeutics USD 7.1B 506M 2025-12
UnitedHealth USD 105.81B 1.03B 2025-09
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 2.56B 230.55M 2025-12
West Pharmaceutical Services USD 3.18B 124.5M 2025-12